Guobang Pharma Ltd. (SHA:605507)
China
· Delayed Price · Currency is CNY 20.38
+0.13 (0.64%)
Jun 6, 2025, 2:45 PM CST
Guobang Pharma Revenue
Guobang Pharma had revenue of 1.44B CNY in the quarter ending March 31, 2025, with 7.57% growth. This brings the company's revenue in the last twelve months to 5.99B, up 13.53% year-over-year. In the year 2024, Guobang Pharma had annual revenue of 5.89B with 10.12% growth.
Revenue (ttm)
5.99B
Revenue Growth
+13.53%
P/S Ratio
1.90
Revenue / Employee
1.50M
Employees
4,003
Market Cap
11.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |